Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK.

Keyphrases

• Methicillin-resistant Staphylococcus Aureus 100%
• Laboratory Features 100%
• Epidemiological Characteristics 100%
• Tertiary Care Hospital 100%
• Staphylococcus Aureus Bacteremia 100%
• Glycopeptide Antibiotics 50%
• Hospital Admission 25%
• Antibiotics 25%
• Vancomycin 25%
• Epidemiology 25%
• Poor Outcome 25%
• Epidemiological Data 25%
• Severe Sepsis 25%
• Infection Control Measures 25%
• Laboratory Data 25%
• Clinically Significant 25%
• Common Source 25%
• Minimum Inhibitory Concentration 25%
• Medical Devices 25%
• Hospital-acquired 25%
• Infection Process 25%
• Bacteremia 25%
• Hemodynamic Instability 25%
• New Antibiotics 25%
• Tigecycline 25%
• Antibiotic Use 25%
• Daptomycin 25%
• Heteroresistance 25%
• Vancomycin-intermediate Staphylococcus Aureus 25%
• Intravascular Devices 25%
• Infection Focus 25%
• History of Hospitals 25%
• Linezolid 25%
• Empiric Antibiotics 25%
• HVISA 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Infection 100%
• Methicillin Resistant Staphylococcus Aureus Infection 100%
• Vancomycin 33%
• Antibiotics 33%
• Sepsis 33%
• Minimum Inhibitory Concentration 33%
• Methicillin-Resistant Staphylococcus Aureus 33%
• Tigecycline 33%
• Bloodstream Infection 33%
• Daptomycin 33%
• Polypeptide Antibiotic Agent 33%
• Linezolid 33%
• Vancomycin Intermediate Staphylococcus Aureus 33%
• Glycopeptide 33%

Immunology and Microbiology

• Methicillin-Resistant Staphylococcus Aureus 100%
• Hemodynamic 25%
• Minimum Inhibitory Concentration 25%
• Glycopeptide Antibiotic 25%
• Vancomycin Intermediate Staphylococcus Aureus 25%
• Glycopeptide 25%